We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Heart Disease Risk Factor Found in Post-Menopausal Women

By MedImaging International staff writers
Posted on 14 Feb 2017
Print article
Image: Research shows an increased amount of fat around the heart can present a higher risk of heart disease in post-menopausal women (Photo courtesy of UPMC).
Image: Research shows an increased amount of fat around the heart can present a higher risk of heart disease in post-menopausal women (Photo courtesy of UPMC).
Researchers have found that an increased volume of paracardial fat around the heart poses a significantly higher risk of heart disease for post-menopausal women, as well as for midlife women with lower levels of estrogen.

The study included 478 menopausal women in the US who were enrolled in the Study of Women's Health Across the Nation (SWAN) program. The women were 51 years old on average, and were not on hormone replacement therapy. The researchers used blood samples and Computed Tomography (CT) scans of the heart to determine the epicardial and paracardial fat levels.

The researchers from the University of Pittsburgh Graduate School of Public Health published the results of the study online in the January 20, 2017, issue of the Journal of the American Heart Association.

The results indicated that a 60% increase in paracardial fat volume was associated with a 160% increase in the risk of coronary artery calcification. There was also 45% more coronary artery calcification in postmenopausal women than in women before menopause, or those in early-menopausal stages.

Samar R. El Khoudary, PhD, MPH, lead author of the study, said, "For the first time, we've pinpointed the type of heart fat, linked it to a risk factor for heart disease and shown that menopausal status and estrogen levels are critical modifying factors of its associated risk in women. Clearly, epicardial and paracardial fat are distinct types of heart fat that are found to be greater in postmenopausal women for different reasons with different effects on heart disease risk--and thus should be evaluated separately when searching for ways to help women avoid heart disease."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Digital Radiography Acquisition Software
VXvue with PureImpact
Dose Calibration Electrometer
PC Electrometer
New
Portable Radiology System
DRAGON ELITE & CLASSIC

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.